RxDoctor Payments Data

Megan Steach

Psychiatric/Mental Health · Southlake, TXNPI 1871045153

Payments from drug & device makers

$7,677in general payments, 2019–2025

Across 379 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$910
  • Teva Pharmaceuticals USA, Inc.$886
  • Neurocrine Biosciences, Inc.$708
  • Axsome Therapeutics, Inc.$698
  • Corium, LLC$633
  • Alkermes, Inc.$546
  • plus $3K from 22 others

What the payments were for

  • Consulting fees$1502%
  • Food & beverage$7,41197%
  • Education$1162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,677 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine12$150,754
IngrezzaValbenazine Tosylate12$101,349
ViibrydVilazodone Hcl12$3,879
Duloxetine Hcl14$429
Olanzapine11$421
Aripiprazole15$377
Quetiapine Fumarate15$374
Trazodone Hcl38$327
Gabapentin15$284
Sertraline Hcl18$263
Lamotrigine15$250
Fluoxetine Hcl30$202
Bupropion XlBupropion Hcl14$189
Clonazepam16$184
Citalopram HbrCitalopram Hydrobromide17$128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$886$150,75412 claims
Neurocrine Biosciences, Inc.Ingrezza$708$101,34912 claims
AbbVieViibryd$311$3,87912 claims
Almatica Pharma LLCSertraline Hcl$29$26318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Southlake

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →